SunOpta, Inc. (NASDAQ:STKL) (TSE:SOY) Director M Shan Atkins purchased 12,500 shares of the company’s stock in a transaction on Friday, May 12th. The stock was purchased at an average cost of $8.02 per share, for a total transaction of $100,250.00. Following the purchase, the director now directly owns 25,881 shares in the company, valued at $207,565.62. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.
SunOpta, Inc. (NASDAQ:STKL) traded down 2.11% during trading on Friday, reaching $9.30. The company had a trading volume of 256,388 shares. SunOpta, Inc. has a one year low of $3.87 and a one year high of $9.95. The company’s market capitalization is $799.90 million. The company has a 50-day moving average price of $8.80 and a 200 day moving average price of $7.54.
SunOpta (NASDAQ:STKL) (TSE:SOY) last announced its earnings results on Wednesday, May 10th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.01. The company had revenue of $330 million during the quarter, compared to analyst estimates of $344.20 million. SunOpta had a negative net margin of 3.95% and a positive return on equity of 0.58%. The firm’s quarterly revenue was down 6.3% compared to the same quarter last year. During the same period in the previous year, the business posted $0.03 earnings per share. Analysts expect that SunOpta, Inc. will post $0.08 earnings per share for the current year.
STKL has been the subject of several analyst reports. Wunderlich cut SunOpta from a “buy” rating to a “hold” rating and decreased their price objective for the company from $10.00 to $8.00 in a report on Thursday, March 2nd. DA Davidson cut SunOpta from a “buy” rating to a “neutral” rating in a report on Monday, March 6th. William Blair upgraded SunOpta from a “market perform” rating to an “outperform” rating in a report on Tuesday, March 7th. Zacks Investment Research cut SunOpta from a “hold” rating to a “strong sell” rating in a report on Thursday, March 9th. Finally, BMO Capital Markets restated a “buy” rating and issued a $8.50 price objective on shares of SunOpta in a report on Wednesday, April 26th. Four investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $9.10.
Institutional investors have recently bought and sold shares of the company. Morgan Stanley raised its position in SunOpta by 1.1% in the third quarter. Morgan Stanley now owns 8,023,782 shares of the company’s stock worth $56,648,000 after buying an additional 89,567 shares during the last quarter. Empyrean Capital Partners LP raised its position in SunOpta by 54.8% in the third quarter. Empyrean Capital Partners LP now owns 1,548,000 shares of the company’s stock worth $10,929,000 after buying an additional 548,000 shares during the last quarter. Ardsley Advisory Partners purchased a new position in SunOpta during the third quarter worth $25,628,000. UBS Group AG raised its position in SunOpta by 16.9% in the third quarter. UBS Group AG now owns 3,678,363 shares of the company’s stock worth $25,969,000 after buying an additional 531,783 shares during the last quarter. Finally, State Street Corp raised its position in SunOpta by 1.0% in the fourth quarter. State Street Corp now owns 34,134 shares of the company’s stock worth $241,000 after buying an additional 326 shares during the last quarter. Institutional investors and hedge funds own 87.14% of the company’s stock.
SunOpta Inc operates businesses focused on a healthy products portfolio. The Company operates through two segments: Global Ingredients and Consumer Products. The Global Ingredients segment aggregates its North American and international raw material sourcing and supply operating segments focused on the procurement, processing and sale of specialty and organic grains, seeds, fruits, grain- and cocoa-based ingredients, and other commodities, which are used in applications serving the natural and organic food industry.
Receive News & Ratings for SunOpta Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SunOpta Inc. and related companies with MarketBeat.com's FREE daily email newsletter.